ID

14212

Beschreibung

A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus; ODM derived from: https://clinicaltrials.gov/show/NCT01698723

Link

https://clinicaltrials.gov/show/NCT01698723

Stichworte

  1. 04.04.16 04.04.16 -
Hochgeladen am

4. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute on Chronic Hepatic Failure NCT01698723

Eligibility Acute on Chronic Hepatic Failure NCT01698723

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
all aclf due to hev
Beschreibung

Acute-On-Chronic Liver Failure

Datentyp

boolean

Alias
UMLS CUI [1]
C3850141
consent to participate in trial and collection of blood
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant and nursing mothers
Beschreibung

Patient pregnant

Datentyp

boolean

Alias
UMLS CUI [1]
C0549206
severe anemia
Beschreibung

Anemia, severe

Datentyp

boolean

Alias
UMLS CUI [1]
C0238644
other etiologies of aclf (eg. alcohol, drugs, reactivation of hepatitis b and hepatitis c, variceal bleeding, surgical intervention and sepsis)
Beschreibung

other etiologies of aclf

Datentyp

boolean

Alias
UMLS CUI [1]
C3850141
hepatocellular carcinoma (hcc)
Beschreibung

Liver carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2239176
hepatorenal syndrome (hrs) at admission
Beschreibung

Hepatorenal Syndrome

Datentyp

boolean

Alias
UMLS CUI [1]
C0019212
presence of life threatening cardiovascular, respiratory and neurological disease
Beschreibung

Life Threatening Adverse Event

Datentyp

boolean

Alias
UMLS CUI [1]
C1517874
acquired immunodeficiency syndrome
Beschreibung

Acquired Immunodeficiency Syndrome

Datentyp

boolean

Alias
UMLS CUI [1]
C0001175
patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia)
Beschreibung

Hemoglobinopathies

Datentyp

boolean

Alias
UMLS CUI [1]
C0019045
refusal to provide consent to participate in the study
Beschreibung

participate in the study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568

Ähnliche Modelle

Eligibility Acute on Chronic Hepatic Failure NCT01698723

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Acute-On-Chronic Liver Failure
Item
all aclf due to hev
boolean
C3850141 (UMLS CUI [1])
Informed Consent
Item
consent to participate in trial and collection of blood
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patient pregnant
Item
pregnant and nursing mothers
boolean
C0549206 (UMLS CUI [1])
Anemia, severe
Item
severe anemia
boolean
C0238644 (UMLS CUI [1])
other etiologies of aclf
Item
other etiologies of aclf (eg. alcohol, drugs, reactivation of hepatitis b and hepatitis c, variceal bleeding, surgical intervention and sepsis)
boolean
C3850141 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma (hcc)
boolean
C2239176 (UMLS CUI [1])
Hepatorenal Syndrome
Item
hepatorenal syndrome (hrs) at admission
boolean
C0019212 (UMLS CUI [1])
Life Threatening Adverse Event
Item
presence of life threatening cardiovascular, respiratory and neurological disease
boolean
C1517874 (UMLS CUI [1])
Acquired Immunodeficiency Syndrome
Item
acquired immunodeficiency syndrome
boolean
C0001175 (UMLS CUI [1])
Hemoglobinopathies
Item
patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia)
boolean
C0019045 (UMLS CUI [1])
participate in the study
Item
refusal to provide consent to participate in the study
boolean
C2348568 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video